Form 4: ReposiTrak CEO Sells Shares via 10b5-1 Plan
Insider Transaction Report
ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock through a pre-arranged 10b5-1 trading plan to fulfill charitable commitments.
Summary
- Randall K. Fields, CEO, Director, and 10% Owner of ReposiTrak, Inc. (TRAK), reported sales of common stock.
- On August 11, 2025, 4,000 shares were sold directly at a weighted average price of $16.8251 per share, with prices ranging from $16.485 to $17.07.
- On August 12, 2025, an additional 3,500 shares were sold directly at a weighted average price of $16.836 per share, with prices ranging from $16.605 to $17.16.
- The total number of shares sold across these two transactions is 7,500.
- These sales were executed automatically under a Rule 10b5-1 trading plan, established to meet charitable commitments of the Reporting Person as Trustee of the 2022 RK Fields Charitable Remainder Unitrust.
- Following these transactions, Randall K. Fields directly holds 3,683,955 shares of Common Stock.
- Indirect holdings include 109,500 Common Stock via RK Fields Charitable 2022, LLC, 615,260 Common Stock and 531,432 Series B Preferred Stock via Riverview Financial Corp., 30,667 Common Stock and 12,322 Series B Preferred Stock via Spouse, and 333,643 Common Stock via Fields Management, Inc.
Sentiment
Score: 5
Explanation: A neutral score is assigned as this is a routine insider transaction disclosure (Form 4) under a 10b5-1 plan for charitable purposes. While it's a sale, the pre-planned nature and stated reason mitigate negative sentiment, making it neither significantly positive nor negative for the company's operational outlook.
Positives
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned, non-discretionary transaction rather than a reaction to new information.
- The stated purpose of the sales is to meet charitable commitments, which can be viewed positively as a philanthropic act.
Negatives
- An insider sale, even if pre-planned, can sometimes be perceived negatively by the market as it reduces the insider's direct stake in the company.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Management Comments
- The sales were executed automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, established to meet some of his charitable commitments.
Industry Context
This Form 4 filing is a routine disclosure of insider stock transactions and does not provide information directly related to broader industry trends or competitive dynamics. It reflects an individual's pre-planned stock sale rather than a corporate strategic move.
Related Party Transactions
- The sales were conducted by Randall K. Fields, CEO, Director, and 10% Owner, through a Rule 10b5-1 trading plan associated with the 2022 RK Fields Charitable Remainder Unitrust and RK Fields Charitable 2022, LLC, entities related to the reporting person.
Stakeholder Impact
- Shareholders: The sale of shares by a key insider, even if pre-planned, could lead to minor concerns about management's confidence, though the stated charitable purpose and 10b5-1 plan mitigate this. The overall impact on share price is typically limited for routine 10b5-1 sales.
- Employees, Customers, Suppliers, Creditors: No direct impact is indicated by this insider transaction filing.
Key Dates
| Date | Description |
|---|---|
| 08/11/2025 | Transaction date for the sale of 4,000 shares of Common Stock. |
| 08/12/2025 | Transaction date for the sale of 3,500 shares of Common Stock. |
| 08/13/2025 | Date the Form 4 was filed with the SEC. |
Recommendation
holdThis Form 4 filing details a routine, pre-scheduled sale of a relatively small portion of shares by the CEO, Randall K. Fields, executed under a Rule 10b5-1 plan for charitable purposes. Such transactions are typically non-eventful for the company's fundamental outlook and do not signal a change in management's view of the company's prospects. Given the nature of the transaction, it does not provide new information to warrant a change in investment thesis, hence a 'hold' recommendation is appropriate.
Keywords
ReposiTrak, TRAK, SEC Form 4, Insider Trading, Stock Sale, Randall K. Fields, 10b5-1 Plan, Common Stock, CEO, Director, 10% Owner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.